|
MGAT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.986980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.653400E-01 |
| Normal-vs-Stage2 |
4.163400E-01 |
| Normal-vs-Stage3 |
2.379800E-02 |
| Normal-vs-Stage4 |
6.081000E-01 |
| Stage1-vs-Stage2 |
4.615200E-01 |
| Stage1-vs-Stage3 |
2.105800E-02 |
| Stage1-vs-Stage4 |
5.247800E-01 |
| Stage2-vs-Stage3 |
9.621900E-02 |
| Stage2-vs-Stage4 |
9.298200E-01 |
| Stage3-vs-Stage4 |
2.968200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.974800E-01 |
| Normal-vs-AfricanAmerican |
4.695000E-01 |
| Normal-vs-Asian |
2.799800E-01 |
| Caucasian-vs-AfricanAmerican |
9.225800E-01 |
| Caucasian-vs-Asian |
1.020020E-01 |
| AfricanAmerican-vs-Asian |
1.401370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.827400E-01 |
| Normal-vs-Female |
1.665760E-02 |
| Male-vs-Female |
1.741740E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.391000E-01 |
| Normal-vs-Extreme_Weight |
9.913000E-01 |
| Normal-vs-Obese |
1.140010E-01 |
| Normal-vs-Extreme_Obese |
3.674600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.122000E-01 |
| Normal_Weight-vs-Obese |
2.974000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.434600E-01 |
| Extreme_Weight-vs-Obese |
1.051350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.783800E-01 |
| Obese-vs-Extreme_Obese |
2.215400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.207700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.628300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.349400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.455400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.422100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.461700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.745770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.042200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.079760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.982600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.789800E-01 |
| Normal-VS-Type2 PRCC |
4.939000E-01 |
| Normal-VS-KIRP CIMP |
2.639800E-02 |
| Normal-VS-Unclassified PRCC |
1.225230E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.571800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.057600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.832820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.674000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.251800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.580200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.036000E-01 |
| Normal-vs-N1 |
1.379630E-02 |
| Normal-vs-N2 |
5.861200E-01 |
| N0-vs-N1 |
2.508200E-02 |
| N0-vs-N2 |
6.557600E-01 |
| N1-vs-N2 |
2.121200E-01 |
|
|
